STERIS exec has 195 shares withheld for taxes

STERIS plc senior vice president Julia Madsen reported a routine tax-withholding transaction tied to vesting equity awards.

Rhea-AI Filing Summary

STERIS plc senior vice president Julia Madsen reported a routine tax-withholding transaction tied to vesting equity awards. On June 4, 2026, 195 ordinary shares were disposed of at $212.24 per share to cover taxes due on 542 restricted shares that vested that day.

After this withholding, Madsen directly holds 12,257 ordinary shares of STERIS, including 4,190 restricted shares as of June 8, 2026. These restricted shares are scheduled to lapse in tranches between June 2, 2027 and June 4, 2029.

Insider Trade Summary

Exercise Price or Tax Liability: 195 shares

Exercise Price or Tax Liability 1 txn

Insider Madsen Julia

Role Sr. VP and GM, Life Sciences

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Ordinary Shares	195	$212.24	$41K

Holdings After Transaction: Ordinary Shares — 12,257 shares (Direct)

Footnotes (2)

1. F1. 195 shares were withheld from the 542 restricted shares that vested on June 4, 2026. These 195 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026.
2. F2. As of June 8, 2026, 4,190 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.

Key Figures

Shares withheld for taxes: 195 shares Withholding price: $212.24 per share Restricted shares vested: 542 shares +3 more

6 metrics

Shares withheld for taxes 195 shares Tax-withholding disposition on June 4, 2026

Withholding price $212.24 per share NYSE closing market price on June 4, 2026

Restricted shares vested 542 shares Restricted shares vesting on June 4, 2026

Total shares after transaction 12,257 shares Ordinary shares directly held following transaction

Restricted shares outstanding 4,190 shares Restricted as of June 8, 2026

Future vesting dates 6 dates from 2027 to 2029 Restrictions lapse between June 2, 2027 and June 4, 2029

Key Terms

restricted shares, taxes required to be withheld, NYSE closing market price, Sr. VP and GM, Life Sciences

4 terms

restricted shares financial

"542 restricted shares that vested on June 4, 2026."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

taxes required to be withheld financial

"represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws"

NYSE closing market price financial

"These vested shares were valued at the NYSE closing market price on June 4, 2026."

Sr. VP and GM, Life Sciences financial

"officer_title": "Sr. VP and GM, Life Sciences""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did STERIS (STE) report for Julia Madsen?

STERIS reported that Sr. VP Julia Madsen had 195 ordinary shares withheld to pay taxes on vesting equity. The withholding related to 542 restricted shares that vested on June 4, 2026, and reflects a standard compensation-related tax settlement.

Was the STERIS (STE) insider transaction a market sale of shares?

No, the transaction was not an open-market sale. The 195 STERIS ordinary shares were withheld by the company to satisfy tax obligations on 542 restricted shares that vested on June 4, 2026, using the NYSE closing market price that day.

How many STERIS (STE) shares does Julia Madsen hold after this filing?

After the tax-withholding disposition, Julia Madsen directly holds 12,257 STERIS ordinary shares. According to the filing, 4,190 of these are restricted as of June 8, 2026, subject to scheduled lapses over future years.

How many restricted STERIS (STE) shares vested for Julia Madsen on June 4, 2026?

On June 4, 2026, 542 restricted STERIS ordinary shares vested for Julia Madsen. From this vesting, 195 shares were withheld to cover required taxes, valued at the NYSE closing market price on that date, as determined by the company.

When do Julia Madsen’s remaining restricted STERIS (STE) shares lapse?

The filing states that 4,190 of Madsen’s ordinary shares remain restricted as of June 8, 2026. These restrictions lapse in tranches on June 2, 2027, June 3, 2027, June 4, 2027, June 2, 2028, June 5, 2028, and June 4, 2029.

What price was used to value the STERIS (STE) shares withheld for taxes?

The 195 STERIS shares withheld for taxes were valued at $212.24 per share. This amount reflects the NYSE closing market price on June 4, 2026, the same date the 542 restricted shares vested for Julia Madsen.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Madsen Julia

(Last) (First) (Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP and GM, Life Sciences

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/04/2026		F		195(1)	D	$212.24	12,257(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. 195 shares were withheld from the 542 restricted shares that vested on June 4, 2026. These 195 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026.

2. As of June 8, 2026, 4,190 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 772 on June 2, 2027; 666 on June 3, 2027; 542 on June 4, 2027; 772 on June 2, 2028; 666 on June 5, 2028 and 772 on June 4, 2029.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)